November 16, 2011 by staff
The 6.6 million Avaira Sphere lenses affected by the recall contained excess silicone residue and failed to meet FDA quality requirements. The silicone residue can cause hazy vision, discomfort, severe eye pain or injuries requiring medical treatment.
CooperVision intends to replace the recalled lenses with untainted Avaira Sphere inventory.
“The company is confident we found the problem and have taken corrective action to fix the problem,” Christine Moench, CooperVision’s vice president of global regulatory affairs & quality assurance in prepared remarks. “The health and safety of our customers is our top priority.”
CooperVision launched a recall site today, where contact wearers can enter lens numbers to see if their lenses are impacted.
Please feel free to send if you have any questions regarding this post , you can contact on
Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.